[1]

Tobe LA, Harris A, Hussain RM, Eckert G, Huck A, et al. 2015. The role of retrobulbar and retinal circulation on optic nerve head and retinal nerve fibre layer structure in patients with open-angle glaucoma over an 18-month period. The British Journal of Ophthalmology 99:609−612

doi: 10.1136/bjophthalmol-2014-305780
[2]

Jin H, Seo JH, Lee Y, Won S. 2025. Genetic risk factors associated with ocular perfusion pressure in primary open-angle glaucoma. Human Genomics 19:31

doi: 10.1186/s40246-025-00738-5
[3]

Chung C, Dai M, Lin J, Wang Z, Chen H, et al. 2019. Correlation of iris collagen and in-vivo anterior segment structures in patients in different stages of chronic primary angle-closure in both eyes. Indian Journal of Ophthalmology 67:1638−1644

doi: 10.4103/ijo.IJO_1406_18
[4]

Skalicky SE, Martin KR, Fenwick E, Crowston JG, Goldberg I, et al. 2015. Cataract and quality of life in patients with glaucoma. Clinical & Experimental Ophthalmology 43:335−341

doi: 10.1111/ceo.12454
[5]

Noyola-Martínez N, Halhali A, Barrera D. 2019. Steroid hormones and pregnancy. Gynecological Endocrinology 35:376−384

doi: 10.1080/09513590.2018.1564742
[6]

Del Río JP, Alliende MI, Molina N, Serrano FG, Molina S, et al. 2018. Steroid hormones and their action in women's brains: the importance of hormonal balance. Frontiers in Public Health 6:141

doi: 10.3389/fpubh.2018.00141
[7]

Rege J, Turcu AF, Else T, Auchus RJ, Rainey WE. 2019. Steroid biomarkers in human adrenal disease. The Journal of Steroid Biochemistry and Molecular Biology 190:273−280

doi: 10.1016/j.jsbmb.2019.01.018
[8]

Vegeto E, Villa A, Della Torre S, Crippa V, Rusmini P, et al. 2020. The role of sex and sex hormones in neurodegenerative diseases. Endocrine Reviews 41:273−319

doi: 10.1210/endrev/bnz005
[9]

Ghayee HK, Auchus RJ. 2007. Basic concepts and recent developments in human steroid hormone biosynthesis. Reviews in Endocrine and Metabolic Disorders 8:289−300

doi: 10.1007/s11154-007-9052-2
[10]

Vaidya A, Carey RM. 2020. Evolution of the primary aldosteronism syndrome: updating the approach. The Journal of Clinical Endocrinology and Metabolism 105:3771−3783

doi: 10.1210/clinem/dgaa606
[11]

Tritos NA. 2021. Adrenally directed medical therapies for cushing syndrome. The Journal of Clinical Endocrinology and Metabolism 106:16−25

doi: 10.1210/clinem/dgaa778
[12]

Schellevis RL, Altay L, Kalisingh A, Mulders TWF, Sitnilska V, et al. 2019. Elevated steroid hormone levels in active chronic central serous chorioretinopathy. Investigative Ophthalmology & Visual Science 60:3407−3413

doi: 10.1167/iovs.19-26781
[13]

Li S, Ren J, Jiang Z, Qiu Y, Shao M, et al. 2024. Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression. eLife 12:RP91407

doi: 10.7554/eLife.91407
[14]

McKay TB, Priyadarsini S, Karamichos D. 2022. Sex hormones, growth hormone, and the cornea. Cells 11:224

doi: 10.3390/cells11020224
[15]

Youngblood H, Schoenlein PV, Pasquale LR, Stamer WD, Liu Y. 2023. Estrogen dysregulation, intraocular pressure, and glaucoma risk. Experimental Eye Research 237:109725

doi: 10.1016/j.exer.2023.109725
[16]

Nuzzi R, Caselgrandi P. 2022. Sex hormones and their effects on ocular disorders and pathophysiology: current aspects and our experience. International Journal of Molecular Sciences 23:3269

doi: 10.3390/ijms23063269
[17]

Roberti G, Oddone F, Agnifili L, Katsanos A, Michelessi M, et al. 2020. Steroid-induced glaucoma: epidemiology, pathophysiology, and clinical management. Survey of Ophthalmology 65:458−472

doi: 10.1016/j.survophthal.2020.01.002
[18]

The AGIS investigators. 2000. The advanced glaucoma intervention study (AGIS): the relationship between control of intraocular pressure and visual field deterioration. American Journal of Ophthalmology 130:429−440

doi: 10.1016/s0002-9394(00)00538-9
[19]

Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, et al. 1991. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore eye survey. JAMA 266:369−374

doi: 10.1001/jama.1991.03470030069026
[20]

Lewis JM, Priddy T, Judd J, Gordon MO, Kass MA, et al. 1988. Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma. American Journal of Ophthalmology 106:607−612

doi: 10.1016/0002-9394(88)90595-8
[21]

Du S, Huang W, Zhang X, Wang J, Wang W, et al. 2016. Multiplex cytokine levels of aqueous humor in acute primary angle-closure patients: fellow eye comparison. BMC Ophthalmology 16:6

doi: 10.1186/s12886-016-0182-8
[22]

Tezel G. 2021. Multiplex protein analysis for the study of glaucoma. Expert Review of Proteomics 18:911−924

doi: 10.1080/14789450.2021.1996232
[23]

Liu X, Liu X, Wang Y, Sun H, Guo Z, et al. 2021. Proteome characterization of glaucoma aqueous humor. Molecular & Cellular Proteomics 20:100117

doi: 10.1016/j.mcpro.2021.100117
[24]

Wang Y, Chen S, Liu Y, Huang W, Li X, et al. 2018. Inflammatory cytokine profiles in eyes with primary angle-closure glaucoma. Bioscience Reports 38:BSR20181411

doi: 10.1042/BSR20181411
[25]

Zeleznik OA, Kang JH, Lasky-Su J, Eliassen AH, Frueh L, et al. 2023. Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank. Nature Communications 14:2860

doi: 10.1038/s41467-023-38466-w
[26]

Wang Y, Xu W, Zhou D, Neckers L, Chen S, et al. 2014. Coordinated regulation of serum- and glucocorticoid-inducible kinase 3 by a C-terminal hydrophobic motif and Hsp90-Cdc37 chaperone complex. ournal of Biological Chemistry 289:4815−4826

doi: 10.1074/jbc.M113.518480
[27]

Rozsíval P, Hampl R, Obenberger J, Stárka L, Řehák S. 1981. Aqueous humour and plasma cortisol levels in glaucoma and cataract patients. Current Eye Research 1:391−396

doi: 10.3109/02713688109019976
[28]

Kasimov EM, Aghaeva FA. 2017. Cortisol levels in plasma and aqueous humour of patients with steroid induced and other glaucomas. Vestnik Oftalmologii 133:39−45 (in Russian)

doi: 10.17116/oftalma2017133239-44
[29]

Zola M, Bousquet E, Bourges JL, Azan F, Zhao M, et al. 2023. Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR). Scientific Reports 13:14111

doi: 10.1038/s41598-023-41126-0
[30]

Chou T, Huang X, Liu J, Liu X, Zeng K, et al. 2022. First evidence indicates the physiology- and axial-myopia-dependent profiles of steroid hormones in aqueous humor. Metabolites 12:1220

doi: 10.3390/metabo12121220
[31]

Ong AY, Ng SM, Vedula SS, Friedman DS. 2021. Lens extraction for chronic angle-closure glaucoma. The Cochrane Database of Systematic Reviews 3:CD005555

doi: 10.1002/14651858.CD005555.pub3
[32]

Committee ADAPP. 2024. Diagnosis and classification of diabetes: standards of care in diabetes − 2024. Diabetes Care 47:S20−S42

doi: 10.2337/dc24-S002
[33]

Braunger BM, Gießl A, Schlötzer-Schrehardt U. 2023. The blood-ocular barriers and their dysfunction: anatomy, physiology, pathology. Klinische Monatsblätter für Augenheilkunde 240:650−661

doi: 10.1055/a-2063-8957
[34]

Valtari A, Posio S, Toropainen E, Balla A, Puranen J, et al. 2024. Comprehensive ocular and systemic pharmacokinetics of dexamethasone after subconjunctival and intravenous injections in rabbits. European Journal of Pharmaceutics and Biopharmaceutics 198:114260

doi: 10.1016/j.ejpb.2024.114260
[35]

Sigurdsson HH, Konráethsdóttir F, Loftsson T, Stefánsson E. 2007. Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye. Acta Ophthalmologica Scandinavica 85:598−602

doi: 10.1111/j.1600-0420.2007.00885.x
[36]

Daull P, Paterson CA, Kuppermann BD, Garrigue JS. 2013. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema. Journal of Ocular Pharmacology and Therapeutics 29:258−269

doi: 10.1089/jop.2012.0044
[37]

Shen J, Durairaj C, Lin T, Liu Y, Burke J. 2014. Ocular pharmacokinetics of intravitreally administered brimonidine and dexamethasone in animal models with and without blood-retinal barrier breakdown. Investigative Ophthalmology & Visual Science 55:1056−1066

doi: 10.1167/iovs.13-13650
[38]

Rauz S, Walker EA, Hughes SV, Coca-Prados M, Hewison M, et al. 2003. Serum- and glucocorticoid-regulated kinase isoform-1 and epithelial sodium channel subunits in human ocular ciliary epithelium. Investigative Ophthalmology & Visual Science 44:1643−1651

doi: 10.1167/iovs.02-0514
[39]

Coca-Prados M, Escribano J. 2007. New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a multifunctional neuroendocrine gland. Progress in Retinal and Eye Research 26:239−262

doi: 10.1016/j.preteyeres.2007.01.002
[40]

Sheppard KE. 2003. Corticosteroid receptors, 11β-hydroxysteroid dehydrogenase, and the heart. Vitamins and Hormones 66:77−112

doi: 10.1016/s0083-6729(03)01003-3
[41]

Clark AF, Wilson K, McCartney MD, Miggans ST, Kunkle M, et al. 1994. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Investigative Ophthalmology & Visual Science 35:281−294
[42]

Raghunathan VK, Morgan JT, Park SA, Weber D, Phinney BS, et al. 2015. Dexamethasone stiffens trabecular meshwork, trabecular meshwork cells, and matrix. Investigative Ophthalmology & Visual Science 56:4447−4459

doi: 10.1167/iovs.15-16739
[43]

Patel PD, Kodati B, Clark AF. 2023. Role of glucocorticoids and glucocorticoid receptors in glaucoma pathogenesis. Cells 12:2452
[44]

Saccà SC, Pulliero A, Izzotti A. 2015. The dysfunction of the trabecular meshwork during glaucoma course. Journal of Cellular Physiology 230:510−525

doi: 10.1002/jcp.24826
[45]

Kersey JP, Broadway DC. 2006. Corticosteroid-induced glaucoma: a review of the literature. Eye 20:407−416

doi: 10.1038/sj.eye.6701895
[46]

Buonfiglio F, Pfeiffer N, Gericke A. 2024. Glaucoma and the ocular renin-angiotensin-aldosterone system: update on molecular signalling and treatment perspectives. Cell Signal 122:111343

doi: 10.1016/j.cellsig.2024.111343
[47]

Johnson TA, Fettweis G, Wagh K, Ceacero-Heras D, Krishnamurthy M, et al. 2024. The glucocorticoid receptor potentiates aldosterone-induced transcription by the mineralocorticoid receptor. Proceedings of the National Academy of Sciences of the United States of America 121:e2413737121

doi: 10.1073/pnas.2413737121
[48]

Alvarez de la Rosa D, Ramos-Hernández Z, Weller-Pérez J, Johnson TA, Hager GL. 2024. The impact of mineralocorticoid and glucocorticoid receptor interaction on corticosteroid transcriptional outcomes. Molecular and Cellular Endocrinology 594:112389

doi: 10.1016/j.mce.2024.112389
[49]

Angelousi A, Margioris AN, Tsatsanis C. 2020. ACTH action on the adrenals. In Endotext [Internet], eds. Feingold KR, Adler RA, Faisal Ahmed S, Anawalt B, Blackman MR et al. South Dartmouth (MA): MDText.com, Inc. www.ncbi.nlm.nih.gov/books/NBK279118/
[50]

Fraccarollo D, Berger S, Galuppo P, Kneitz S, Hein L, et al. 2011. Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction. Circulation 123:400−408

doi: 10.1161/circulationaha.110.983023
[51]

McCurley A, Jaffe IZ. 2012. Mineralocorticoid receptors in vascular function and disease. Molecular and Cellular Endocrinology 350:256−265

doi: 10.1016/j.mce.2011.06.014